GLP-1RAs safely reduces weight, improves glycaemic control in obese kids
Glucagon-like peptide-1 receptor agonists (GLP-1RA) can induce moderate losses in weight, body mass index (BMI), blood pressure, and glycated haemoglobin (HbA1c) in young people with obesity, a recent meta-analysis has shown. Treatment with GLP-1 agonists is also relatively safe and does not impart heightened risks of gastrointestinal symptoms.
